PROJ-SUN_1170x120_6-24-20

rivastigmine patch

Sandoz releases generic of Exelon patch in U.S.

Sandoz releases generic of Exelon patch in U.S.

PRINCETON, N.J. — Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp. Sandoz is marketing its rivastigmine patch in 13.3-mg strength, the same strength as the